Nisa Investment Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9K | Sell |
1,658
-1,319
| -44% | -$42.9K | ﹤0.01% | 1569 |
|
|
2025
Q1 | $112K | Buy |
2,977
+293
| +11% | +$11.1K | ﹤0.01% | 1366 |
|
|
2024
Q4 | $220K | Buy |
2,684
+475
| +22% | +$38.9K | ﹤0.01% | 1268 |
|
|
2024
Q3 | $252K | Buy |
2,209
+110
| +5% | +$12.6K | ﹤0.01% | 1223 |
|
|
2024
Q2 | $158K | Buy |
2,099
+825
| +65% | +$62.3K | ﹤0.01% | 1369 |
|
|
2024
Q1 | $87K | Buy |
1,274
+85
| +7% | +$5.81K | ﹤0.01% | 1508 |
|
|
2023
Q4 | $74.7K | Sell |
1,189
-1,192
| -50% | -$74.9K | ﹤0.01% | 1523 |
|
|
2023
Q3 | $121K | Hold |
2,381
| – | – | ﹤0.01% | 1446 |
|
|
2023
Q2 | $119K | Buy |
2,381
+669
| +39% | +$33.4K | ﹤0.01% | 1467 |
|
|
2023
Q1 | $64K | Sell |
1,712
-54,940
| -97% | -$2.05M | ﹤0.01% | 1639 |
|
|
2022
Q4 | $2.72M | Buy |
56,652
+55,820
| +6,709% | +$2.68M | 0.02% | 638 |
|
|
2022
Q3 | $35K | Buy |
832
+41
| +5% | +$1.73K | ﹤0.01% | 1875 |
|
|
2022
Q2 | $17K | Sell |
791
-739
| -48% | -$15.9K | ﹤0.01% | 2085 |
|
|
2022
Q1 | $37K | Hold |
1,530
| – | – | ﹤0.01% | 1920 |
|
|
2021
Q4 | $29K | Buy |
+1,530
| New | +$29K | ﹤0.01% | 1859 |
|